Colgate Announces 4th Quarter and Full Year 2016 Results
Net income and Diluted earnings per share in fourth quarter 2016 were
Net income (loss) and Diluted earnings (loss) per share in fourth
quarter 2015 were
Excluding charges resulting from the 2012 Restructuring Program and
previously disclosed litigation matters in both periods and the charge
for the deconsolidation of the Company's Venezuelan operations in 2015,
Net income in fourth quarter 2016 was
Gross profit margin was 60.4% in fourth quarter 2016 versus 58.8% in
fourth quarter 2015. Excluding charges from the 2012 Restructuring
Program in both periods, Gross profit margin was 60.8% in fourth quarter
2016, an increase of 180 basis points versus the year ago quarter. This
increase was primarily driven by cost savings from the Company's
funding-the-growth initiatives and the 2012 Restructuring Program, and
higher pricing, partially offset by higher raw and packaging material
costs, which included foreign exchange transaction costs and the impact
of the deconsolidation of the Company's Venezuelan operations effective
Selling, general and administrative expenses were 33.7% of Net sales in
fourth quarter 2016 versus 33.0% of Net sales in fourth quarter 2015.
Excluding charges from the 2012 Restructuring Program in both periods,
Selling, general and administrative expenses increased by 40 basis
points to 32.9% of Net sales in fourth quarter 2016, primarily due to
higher overhead expenses, partially offset by a decrease in advertising
investment, in part reflecting a shift in advertising investment to
in-store promotional activities. Worldwide advertising investment
decreased 8% to
Operating profit (loss) increased to
Net cash provided by operations year-to-date was
For the full year 2016, worldwide Net sales were
Net income and Diluted earnings per share for full year 2016 were
Net income and Diluted earnings per share for full year 2015 were
Excluding the above noted items in both periods, as applicable, Net income for full year 2016 decreased 1% versus full year 2015, and Diluted earnings per share were even with full year 2015. Excluding the above noted items in both periods, as applicable, and excluding Venezuela's operating results in both periods, Diluted earnings per share for full year 2016 increased double digit on a currency-neutral basis.
Gross profit margin was 60.0% for full year 2016 versus 58.6% for full
year 2015. Excluding the above noted items in both periods, as
applicable, Gross profit margin was 60.3% in full year 2016, an increase
of 160 basis points versus full year 2015. This increase was primarily
driven by cost savings from the Company's funding-the-growth initiatives
and the 2012 Restructuring Program, and higher pricing, partially offset
by higher raw and packaging material costs, which included foreign
exchange transaction costs and the impact of the deconsolidation of the
Company's Venezuelan operations effective
"Colgate's leadership of the global toothpaste market continued during the quarter with its global market share now at 44.0% year-to-date. Our global leadership in manual toothbrushes also continued with Colgate's global market share in that category now at 33.1% year-to-date.
"Pleasingly, gross profit margin, operating profit margin and net income as a percent to sales all increased versus the year ago period.
"As we look ahead, uncertainty in global markets and foreign exchange volatility remain challenging, which sees us redoubling our focus on profitable growth. While based on current spot rates, we expect a low-single-digit net sales increase for 2017, we anticipate another year of solid organic sales growth driven by a full new product pipeline, engaging marketing programs and strong advertising support.
"On a GAAP basis, based on current spot rates, we are planning for a year of gross margin expansion and expect earnings per share on a dollar basis to be flat.
"Excluding charges related to the 2012 Restructuring Program and the other 2016 one-time items noted above, based on current spot rates, we are planning for a year of strong operating cash flow, gross margin expansion and increased advertising investment and expect low-single-digit earnings per share growth on a dollar basis."
At
The following are comments about divisional performance for fourth quarter 2016 versus the year ago period. See attached Geographic Sales Analysis Percentage Changes and Segment Information tables for additional information on divisional net sales and operating profit.
North America Net sales, unit volume, pricing, foreign exchange and organic sales were all even with fourth quarter 2015.
Operating profit in
In the U.S., market share gains year-to-date were seen in toothpaste,
manual toothbrushes, mouthwash, liquid hand soap, body wash and liquid
cleaners. Colgate's share of the toothpaste market strengthened to 35.5%
year-to-date, up 0.2 share points versus the year ago period, driven by
strong sales of Colgate Max Fresh Knockout, Colgate Total Daily Repair,
Colgate Optic White Platinum High Impact White, Colgate Sensitive Smart
White and Tom's of Maine Rapid Relief Sensitive toothpastes. In manual
toothbrushes, Colgate strengthened its brand market leadership in the
New products succeeding in other categories include
Latin America Net sales decreased 10.5% in fourth quarter 2016. Unit
volume decreased 16.5% with 9.0% higher pricing, while foreign exchange
was negative 3.0%. Excluding the impact of the deconsolidation of the
Company's Venezuelan operations, unit volume increased 1.5%, driven by
volume gains in
Operating profit in
Colgate strengthened its leadership in toothpaste in
Products in other categories contributing to growth throughout the region include Colgate Plax Ice Glacial mouthwash, Protex Pro-Hidrata shower gel, bar soap and liquid hand soap, Protex for Men 3 in 1 shower gel and bar soap, Palmolive Natural Secrets shower gel and bar soap, Suavitel Sweet Pleasures fabric conditioner, Axion Complete dish liquid and Fabuloso Pure Cleaning liquid cleaner.
Europe Net sales decreased 7.5% in fourth quarter 2016. Unit volume
decreased 2.0%, pricing decreased 1.5% and foreign exchange was negative
4.0%. Volume declines in
Operating profit in
Colgate maintained its oral care leadership in
Premium innovations succeeding in other product categories include
Asia Pacific Net sales decreased 4.0% during fourth quarter 2016. Unit
volume was even with the year ago quarter while pricing decreased 2.0%
and foreign exchange was negative 2.0%. Volume declines in
Operating profit in
Colgate continued its toothpaste leadership in the
New products succeeding in other categories in the region include
Colgate Slim Soft Charcoal Spiral, Colgate Zig Zag Charcoal, Colgate
Super Flexi Black and Colgate Minions™ manual toothbrushes,
Operating profit in
Colgate continued its toothpaste leadership in
Hill's Pet Nutrition (15% of Company Sales)
Hill's Net sales increased 0.5% in fourth quarter 2016. Unit volume
decreased 2.5% with 2.5% higher pricing, while foreign exchange was
positive 0.5%. Volume declines in
Hill's Operating profit increased 7% in fourth quarter 2016 to
Successful products contributing to sales in the
Successful products contributing to sales internationally include Hill's Prescription Diet Metabolic + Mobility and Metabolic + Urinary, Hill's Prescription Diet Derm Defense, Hill's Prescription Diet z/d and Hill's Prescription Diet i/d.
***
About
The Company's annual meeting of shareholders is currently scheduled for
Market Share Information
Management uses market share information as a key indicator to monitor
business health and performance. References to market share in this
press release are based on a combination of consumption and market share
data provided by third-party vendors, primarily Nielsen, and internal
estimates. All market share references represent the percentage of the
dollar value of sales of our products, relative to all product sales in
the category in the countries in which the Company competes and
purchases data (excluding
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking
statements. Such statements may relate, for example, to sales or volume
growth, organic sales growth, profit or profit margin growth, earnings
per share growth (including on a currency-neutral basis), financial
goals, the impact of foreign exchange volatility, cost-reduction plans
including the 2012 Restructuring Program, tax rates, new product
introductions or commercial investment levels, among other matters.
These statements are made on the basis of our views and assumptions as
of this time and we undertake no obligation to update these statements
except as required by law. We caution investors that any such
forward-looking statements are not guarantees of future performance and
that actual events or results may differ materially from those
statements. Investors should consult the Company's filings with the
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
This release discusses Net sales growth (GAAP) and organic sales growth,
which is Net sales growth excluding the impact of foreign exchange,
acquisitions, divestments and the deconsolidation of the Company's
Venezuelan operations (non-GAAP). Management believes the organic sales
growth measure provides investors and analysts with useful supplemental
information regarding the Company's underlying sales trends by
presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions, divestments and the
deconsolidation of the Company's Venezuelan operations. See "Geographic
Sales Analysis Percentage Changes" for the three and twelve months ended
To supplement Colgate's Condensed Consolidated Statements of Income
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Effective income tax rate, Net income attributable to
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company's ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is not a GAAP
measurement and may not be comparable to similarly titled measures
reported by other companies. See "Condensed Consolidated Statements of
Cash Flows" for the twelve months ended
Explanatory Note Regarding Currency-Neutral Calculations
Diluted earnings per share growth for fourth quarter 2016, on a
currency-neutral basis, eliminates from Diluted earnings per share
growth (GAAP) charges resulting from the 2012 Restructuring Program,
charges from previously disclosed litigation matters, a charge related
to the deconsolidation of the Company's Venezuelan operations, 2015 and
2016 Venezuela results and period-over-period changes in foreign
exchange rates in the translation of local currency results into
Diluted earnings per share growth for full year 2016, on a
currency-neutral basis, eliminates from Diluted earnings per share
growth (GAAP) charges resulting from the 2012 Restructuring Program,
charges for previously disclosed litigation matters, a charge related to
the deconsolidation of the Company's Venezuelan operations, 2015 and
2016 Venezuela results, a gain on the sale of land in
Management's estimate of Diluted earnings per share growth on a
currency-neutral basis for full year 2017 eliminates from Diluted
earnings per share growth (GAAP) the impact of the 2016 items described
in Table 9, the 2012 Restructuring Program and period-over-period
changes in foreign exchange rates in the translation of local currency
results into
(See attached tables for fourth quarter and full year results.)
Table 1 | ||||||||
|
||||||||
Condensed Consolidated Statements of Income | ||||||||
For the Three Months Ended |
||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||
2016 | 2015 | |||||||
Net sales | $ | 3,721 | $ | 3,899 | ||||
Cost of sales | 1,474 | 1,606 | ||||||
Gross profit | 2,247 | 2,293 | ||||||
Gross profit margin | 60.4 | % | 58.8 | % | ||||
Selling, general and administrative expenses | 1,253 | 1,286 | ||||||
Other (income) expense, net | 39 | 62 | ||||||
Charge for |
— | 1,084 | ||||||
Operating profit (loss) | 955 | (139 | ) | |||||
Operating profit margin | 25.7 | % |
(3.6) |
% |
||||
Interest (income) expense, net | 21 | 7 | ||||||
Income (loss) before income taxes | 934 | (146 | ) | |||||
Provision for income taxes | 306 | 275 | ||||||
Effective tax rate | 32.8 | % |
(188.4) |
% |
||||
Net income (loss) including noncontrolling interests | 628 | (421 | ) | |||||
Less: Net income attributable to noncontrolling interests | 22 | 37 | ||||||
Net income (loss) attributable to |
$ | 606 | $ | (458 | ) | |||
Earnings (loss) per common share | ||||||||
Basic | $ | 0.68 | $ | (0.51 | ) | |||
Diluted (1) | $ | 0.68 | $ | (0.51 | ) | |||
Average common shares outstanding | ||||||||
Basic | 887.7 | 896.5 | ||||||
Diluted (1) | 893.2 | 896.5 |
Note:
(1)The computation for Diluted (loss) per common share for
the three months ended
Table 2 | ||||||||
|
||||||||
Condensed Consolidated Statements of Income | ||||||||
For the Twelve Months Ended |
||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||
2016 | 2015 | |||||||
Net sales | $ | 15,195 | $ | 16,034 | ||||
Cost of sales | 6,072 | 6,635 | ||||||
Gross profit | 9,123 | 9,399 | ||||||
Gross profit margin | 60.0 | % | 58.6 | % | ||||
Selling, general and administrative expenses | 5,249 | 5,464 | ||||||
Other (income) expense, net | 37 | 62 | ||||||
Charge for |
— | 1,084 | ||||||
Operating profit | 3,837 | 2,789 | ||||||
Operating profit margin | 25.3 | % | 17.4 | % | ||||
Interest (income) expense, net | 99 | 26 | ||||||
Income before income taxes | 3,738 | 2,763 | ||||||
Provision for income taxes | 1,152 | 1,215 | ||||||
Effective tax rate | 30.8 | % | 44.0 | % | ||||
Net income including noncontrolling interests | 2,586 | 1,548 | ||||||
Less: Net income attributable to noncontrolling interests | 145 | 164 | ||||||
Net income attributable to |
$ | 2,441 | $ | 1,384 | ||||
Earnings per common share | ||||||||
Basic | $ | 2.74 | $ | 1.53 | ||||
Diluted | $ | 2.72 | $ | 1.52 | ||||
Average common shares outstanding | ||||||||
Basic | 891.8 | 902.2 | ||||||
Diluted | 898.4 | 909.7 | ||||||
Table 3 | ||||||||
|
||||||||
Condensed Consolidated Balance Sheets | ||||||||
As of |
||||||||
(Dollars in Millions) (Unaudited) | ||||||||
|
|
|||||||
2016 | 2015 | |||||||
Cash and cash equivalents | $ | 1,315 | $ | 970 | ||||
Receivables, net | 1,411 | 1,427 | ||||||
Inventories | 1,171 | 1,180 | ||||||
Other current assets | 441 | 807 | ||||||
Property, plant and equipment, net | 3,840 | 3,796 | ||||||
Other assets, including goodwill and intangibles* | 3,945 | 3,755 | ||||||
Total assets | $ | 12,123 | $ | 11,935 | ||||
Total debt* | $ | 6,533 | $ | 6,548 | ||||
Other current liabilities | 3,292 | 3,232 | ||||||
Other non-current liabilities | 2,281 | 2,199 | ||||||
Total liabilities | 12,106 | 11,979 | ||||||
|
(243 | ) | (299 | ) | ||||
Noncontrolling interests | 260 | 255 | ||||||
Total liabilities and shareholders' equity | $ | 12,123 | $ | 11,935 | ||||
Supplemental Balance Sheet Information | ||||||||
Debt less cash, cash equivalents and marketable securities** | $ | 5,147 | $ | 5,476 | ||||
Working capital % of sales |
(2.2) |
% |
0.5 | % |
*To conform to the current year presentation required by the FASB Accounting Standards Update No. 2015-03 "Simplifying the Presentation of Debt Issuance Costs," prior period balances of debt issuance costs have been reclassified from Other assets, including goodwill and intangibles, and are now presented as a direct deduction to Total debt.
**Marketable securities of
Table 4 | ||||||||
|
||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||
For the Twelve Months Ended |
||||||||
(Dollars in Millions) (Unaudited) | ||||||||
2016 | 2015 | |||||||
Operating Activities | ||||||||
Net income including noncontrolling interests | $ | 2,586 | $ | 1,548 | ||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | ||||||||
Depreciation and amortization | 443 | 449 | ||||||
Restructuring and termination benefits, net of cash | (9 | ) | 69 | |||||
|
— | 34 | ||||||
Stock-based compensation expense | 123 | 125 | ||||||
Gain on sale of land in |
(97 | ) |
|
— | ||||
Gain on sale of |
— | (187 | ) | |||||
Charge for |
— | 1,084 | ||||||
Deferred income taxes | 56 | (51 | ) | |||||
Voluntary benefits plan contributions | (53 | ) | — | |||||
Cash effects of changes in: | ||||||||
Receivables | (17 | ) | (75 | ) | ||||
Inventories | (4 | ) | (13 | ) | ||||
Accounts payable and other accruals | 100 | (67 | ) | |||||
Other non-current assets and liabilities | 13 | 33 | ||||||
Net cash provided by operations | 3,141 | 2,949 | ||||||
Investing Activities | ||||||||
Capital expenditures | (593 | ) | (691 | ) | ||||
Sale of property and non-core products | — | 9 | ||||||
Purchases of marketable securities and investments | (336 | ) | (742 | ) | ||||
Proceeds from sale of marketable securities and investments | 378 | 599 | ||||||
Proceeds from sale of land in |
60 | — | ||||||
Proceeds from sale of |
— | 221 | ||||||
Payment for acquisitions, net of cash acquired | (5 | ) | (13 | ) | ||||
Reduction in cash due to |
— | (75 | ) | |||||
Other | (3 | ) | 7 | |||||
Net cash used in investing activities | (499 | ) | (685 | ) | ||||
Financing Activities | ||||||||
Principal payments on debt | (7,274 | ) | (9,181 | ) | ||||
Proceeds from issuance of debt | 7,438 | 9,602 | ||||||
Dividends paid | (1,508 | ) | (1,493 | ) | ||||
Purchases of treasury shares | (1,335 | ) | (1,551 | ) | ||||
Proceeds from exercise of stock options and excess tax benefits | 446 | 347 | ||||||
Net cash used in financing activities | (2,233 | ) | (2,276 | ) | ||||
Effect of exchange rate changes on Cash and cash equivalents | (64 | ) | (107 | ) | ||||
Net increase (decrease) in Cash and cash equivalents | 345 | (119 | ) | |||||
Cash and cash equivalents at beginning of the period | 970 | 1,089 | ||||||
Cash and cash equivalents at end of the period | $ | 1,315 | $ | 970 | ||||
Supplemental Cash Flow Information | ||||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | ||||||||
Net cash provided by operations | $ | 3,141 | $ | 2,949 | ||||
Less: Capital expenditures | (593 | ) | (691 | ) | ||||
Free cash flow before dividends | $ | 2,548 | $ | 2,258 | ||||
Income taxes paid | $ | 932 | $ | 1,259 | ||||
Table 5 | ||||||||||||||||
|
||||||||||||||||
Segment Information | ||||||||||||||||
For the Three and Twelve Months Ended |
||||||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||||||
Three Months Ended |
Twelve Months Ended |
|||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||
|
||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
|
$ | 790 | $ | 789 | $ | 3,183 | $ | 3,149 | ||||||||
|
940 | 1,050 | 3,650 | 4,327 | ||||||||||||
|
539 | 582 | 2,342 | 2,411 | ||||||||||||
|
633 | 658 | 2,796 | 2,937 | ||||||||||||
|
240 | 244 | 960 | 998 | ||||||||||||
Total Oral, Personal and Home Care | 3,142 | 3,323 | 12,931 | 13,822 | ||||||||||||
Pet Nutrition | 579 | 576 | 2,264 | 2,212 | ||||||||||||
Total |
$ | 3,721 | $ | 3,899 | $ | 15,195 | $ | 16,034 | ||||||||
Three Months Ended |
Twelve Months Ended |
|||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||
Operating Profit (Loss) | ||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
|
$ | 268 | $ | 275 | $ | 1,030 | $ | 974 | ||||||||
|
303 | 280 | 1,132 | 1,209 | ||||||||||||
|
142 | 149 | 579 | 615 | ||||||||||||
|
219 | 212 | 887 | 888 | ||||||||||||
|
48 | 50 | 186 | 178 | ||||||||||||
Total Oral, Personal and Home Care | 980 | 966 | 3,814 | 3,864 | ||||||||||||
Pet Nutrition | 174 | 162 | 653 | 612 | ||||||||||||
Corporate(1) | (199 | ) | (1,267 | ) | (630 | ) | (1,687 | ) | ||||||||
Total Operating Profit (Loss) | $ | 955 | $ | (139 | ) | $ | 3,837 | $ | 2,789 |
Note:
(1) Corporate operations include costs related to stock
options and restricted stock units, research and development costs,
Corporate overhead costs, restructuring and related implementation costs
and gains and losses on sales of non-core product lines and assets.
Corporate Operating profit (loss) for the three months ended
Corporate Operating profit (loss) for the twelve months ended
Table 6 | ||||||||||||||
|
||||||||||||||
Geographic Sales Analysis Percentage Changes | ||||||||||||||
For the Three Months Ended |
||||||||||||||
(Unaudited) | ||||||||||||||
COMPONENTS OF SALES CHANGE | ||||||||||||||
Pricing | ||||||||||||||
Coupons | ||||||||||||||
Sales | Consumer & | |||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | ||||||||
Region |
As Reported |
Sales Change |
Volume(1) |
Volume |
Volume(2) |
Incentives |
Exchange |
|||||||
|
(4.5)% | 1.5% | (5.5)% | (1.0)% | (1.0)% | 2.5% | (1.5)% | |||||||
|
(7.5)% | (3.5)% | (2.0)% | (2.0)% | (2.0)% | (1.5)% | (4.0)% | |||||||
|
(10.5)% | 10.5% | (16.5)% | 1.5% | 1.5% | 9.0% | (3.0)% | |||||||
|
(4.0)% | (2.0)% | —% | —% | —% | (2.0)% | (2.0)% | |||||||
|
(1.5)% | (2.0)% | (12.0)% | (12.0)% | (12.0)% | 10.0% | 0.5% | |||||||
|
(7.0)% | 2.5% | (8.0)% | (1.0)% | (1.0)% | 3.5% | (2.5)% | |||||||
|
—% | —% | —% | —% | —% | —% | —% | |||||||
Total CP Products | (5.5)% | 2.0% | (6.5)% | (1.0)% | (1.0)% | 3.0% | (2.0)% | |||||||
Hill's | 0.5% | —% | (2.5)% | (2.5)% | (2.5)% | 2.5% | 0.5% | |||||||
Emerging Markets (4) | (7.0)% | 4.5% | (10.0)% | (1.0)% | (1.0)% | 5.5% | (2.5)% | |||||||
Developed Markets | (2.0)% | (1.5)% | (1.5)% | (1.5)% | (1.5)% | —% | (0.5)% |
Notes:
(1) As Reported Volume includes the impact of acquisitions,
divestments and the deconsolidation of the Company's Venezuelan
operations, as applicable.
(2) Ex-Divested Volume excludes the impact of divestments and the deconsolidation of the Company's Venezuelan operations, as applicable.
(3) Effective
(4) Emerging Markets include
Table 7 | ||||||||||||||
|
||||||||||||||
Geographic Sales Analysis Percentage Changes | ||||||||||||||
For the Twelve Months Ended |
||||||||||||||
(Unaudited) | ||||||||||||||
COMPONENTS OF SALES CHANGE | ||||||||||||||
Pricing | ||||||||||||||
Coupons | ||||||||||||||
Sales | Consumer & | |||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | ||||||||
Region |
As Reported |
Sales Change |
Volume(1) |
Volume |
Volume(2) |
Incentives |
Exchange |
|||||||
|
(5.0)% | 4.0% | (3.0)% | 1.5% | 1.5% | 2.5% | (4.5)% | |||||||
|
(3.0)% | —% | 2.5% | 2.5% | 2.5% | (2.5)% | (3.0)% | |||||||
|
(15.5)% | 10.0% | (14.0)% | 1.5% | 1.5% | 8.5% | (10.0)% | |||||||
|
(5.0)% | 2.0% | (1.0)% | 2.0% | 2.0% | —% | (4.0)% | |||||||
|
(4.0)% | 5.5% | (4.0)% | (4.0)% | (4.0)% | 9.5% | (9.5)% | |||||||
|
(8.5)% | 5.0% | (5.5)% | 1.5% | 1.5% | 3.5% | (6.5)% | |||||||
|
1.0% | 1.5% | 2.5% | 2.5% | 2.5% | (1.0)% | (0.5)% | |||||||
Total CP Products | (6.5)% | 4.0% | (4.0)% | 1.5% | 1.5% | 2.5% | (5.0)% | |||||||
Hill's | 2.5% | 2.5% | —% | —% | —% | 2.5% | —% | |||||||
Emerging Markets (5) | (9.5)% | 6.5% | (7.0)% | 1.0% | 1.0% | 5.5% | (8.0)% | |||||||
Developed Markets | (1.0)% | 1.0% | 0.5% | 1.5% | 1.5% | (0.5)% | (1.0)% |
Notes:
(1) As Reported Volume includes the impact of acquisitions,
divestments and the deconsolidation of the Company's Venezuelan
operations, as applicable.
(2) Ex-Divested Volume excludes the impact of divestments and the deconsolidation of the Company's Venezuelan operations, as applicable.
(3) Effective
(4) The sale of the Company's laundry detergent business in the
(5) Emerging Markets include
Table 8 | |||||||||||
|
|||||||||||
Non-GAAP Reconciliations | |||||||||||
For the Three Months Ended |
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||
Gross Profit | 2016 | 2015 | |||||||||
Gross profit, GAAP | $ | 2,247 | $ | 2,293 | |||||||
2012 Restructuring Program | 15 | 9 | |||||||||
Gross profit, non-GAAP | $ | 2,262 | $ | 2,302 | |||||||
|
|||||||||||
Gross Profit Margin | 2016 | 2015 | Change | ||||||||
Gross profit margin, GAAP | 60.4 | % | 58.8 | % | 160 | ||||||
2012 Restructuring Program | 0.4 | % | 0.2 | % | |||||||
Gross profit margin, non-GAAP | 60.8 | % | 59.0 | % | 180 | ||||||
Selling, General and Administrative Expenses | 2016 | 2015 | |||||||||
Selling, general and administrative expenses, GAAP | $ | 1,253 | $ | 1,286 | |||||||
2012 Restructuring Program | (28 | ) | (20 | ) | |||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,225 | $ | 1,266 | |||||||
|
|||||||||||
Selling, General and Administrative Expenses as a Percentage of
|
2016 | 2015 | Change | ||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 33.7 | % | 33.0 | % | 70 | ||||||
2012 Restructuring Program | (0.8 | )% | (0.5 | )% | |||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 32.9 | % | 32.5 | % | 40 | ||||||
Other (Income) Expense, Net | 2016 | 2015 | |||||||||
Other (income) expense, net, GAAP | $ | 39 | $ | 62 | |||||||
2012 Restructuring Program | (29 | ) | (27 | ) | |||||||
Charges for previously disclosed litigation matters | (11 | ) | (14 | ) | |||||||
Other (income) expense, net, non-GAAP | $ | (1 | ) | $ | 21 | ||||||
Operating Profit (Loss) | 2016 | 2015 | % Change | ||||||||
Operating profit (loss), GAAP | $ | 955 | $ | (139 | ) | 787 | % | ||||
2012 Restructuring Program | 72 | 56 | |||||||||
Charges for previously disclosed litigation matters | 11 | 14 | |||||||||
|
— | 1,084 | |||||||||
Operating profit, non-GAAP | $ | 1,038 | $ | 1,015 | 2 | % | |||||
|
|||||||||||
Operating Profit Margin | 2016 | 2015 | Change | ||||||||
Operating profit margin, GAAP | 25.7 | % | (3.6 | )% | 2930 | ||||||
2012 Restructuring Program | 1.9 | % | 1.4 | % | |||||||
Charges for previously disclosed litigation matters | 0.3 | % | 0.4 | % | |||||||
|
— | % | 27.8 | % | |||||||
Operating profit margin, non-GAAP | 27.9 | % | 26.0 | % | 190 | ||||||
Table 8 | |||||||||||||||||||||||
Continued | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||||||||
For the Three Months Ended |
|||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||||||||
2016 | |||||||||||||||||||||||
Income Before |
Provision For |
Net Income |
Net Income |
Effective Income |
Diluted Earnings |
||||||||||||||||||
As Reported GAAP | $ | 934 | $ | 306 | $ | 628 | $ | 606 | 32.8 | % | $ | 0.68 | |||||||||||
2012 Restructuring Program | 72 | 18 | 54 | 54 | (0.5 | )% | 0.06 | ||||||||||||||||
Charge for a previously disclosed litigation matter | 11 | 4 | 7 | 7 | — | % | 0.01 | ||||||||||||||||
Non-GAAP | $ | 1,017 | $ | 328 | $ | 689 | $ | 667 | 32.3 | % | $ | 0.75 | |||||||||||
2015 | |||||||||||||||||||||||
Income (Loss) |
Provision For |
Net Income |
Net Income |
Effective |
Diluted |
||||||||||||||||||
As Reported GAAP | $ | (146 | ) | $ | 275 | $ | (421 | ) | $ | (458 | ) | (188.4 | )% | $ | (0.51 | ) | |||||||
|
1,084 | 26 | 1,058 | 1,058 | 220.4 | % | 1.18 | ||||||||||||||||
2012 Restructuring Program | 56 | 15 | 41 | 41 | (0.3 | )% | 0.04 | ||||||||||||||||
Charge for a previously disclosed litigation matter | 14 | — | 14 | 14 | (0.4 | )% | 0.02 | ||||||||||||||||
Non-GAAP | $ | 1,008 | $ | 316 | $ | 692 | $ | 655 | 31.3 | % | $ | 0.73 |
Notes:
(1) The income tax effect on non-GAAP items is calculated
based upon the tax laws and statutory income tax rates applicable in the
tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.
(3) The impact of non-GAAP adjustments on Diluted earnings per share may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.
(4) The computation for Diluted (loss) per common share, GAAP for the
three months ended
Table 9 | |||||||||||
|
|||||||||||
Non-GAAP Reconciliations | |||||||||||
For the Twelve Months Ended |
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||
Gross Profit | 2016 | 2015 | |||||||||
Gross profit, GAAP | $ | 9,123 | $ | 9,399 | |||||||
2012 Restructuring Program | 46 | 20 | |||||||||
Gross profit, non-GAAP | $ | 9,169 | $ | 9,419 | |||||||
|
|||||||||||
Gross Profit Margin | 2016 | 2015 | Change | ||||||||
Gross profit margin, GAAP | 60.0 | % | 58.6 | % | 140 | ||||||
2012 Restructuring Program | 0.3 | % | 0.1 | % | |||||||
Gross profit margin, non-GAAP | 60.3 | % | 58.7 | % | 160 | ||||||
Selling, General and Administrative Expenses | 2016 | 2015 | |||||||||
Selling, general and administrative expenses, GAAP | $ | 5,249 | $ | 5,464 | |||||||
2012 Restructuring Program | (77 | ) | (64 | ) | |||||||
Selling, general and administrative expenses, non-GAAP | $ | 5,172 | $ | 5,400 | |||||||
|
|||||||||||
Selling, General and Administrative Expenses as a Percentage of
|
2016 | 2015 | Change | ||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 34.5 | % | 34.1 | % | 40 | ||||||
2012 Restructuring Program | (0.5 | )% | (0.4 | )% | |||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 34.0 | % | 33.7 | % | 30 | ||||||
Other (Income) Expense, Net | 2016 | 2015 | |||||||||
Other (income) expense, net, GAAP | $ | 37 | $ | 62 | |||||||
2012 Restructuring Program | (105 | ) | (170 | ) | |||||||
Gain on sale of land in |
97 | — | |||||||||
Charges for previously disclosed litigation matters | (17 | ) | (14 | ) | |||||||
|
— | (34 | ) | ||||||||
Gain on sale of |
— | 187 | |||||||||
Other (income) expense, net, non-GAAP | $ | 12 | $ | 31 | |||||||
Operating Profit | 2016 | 2015 | % Change | ||||||||
Operating profit, GAAP | $ | 3,837 | $ | 2,789 | 38 | % | |||||
2012 Restructuring Program | 228 | 254 | |||||||||
Gain on sale of land in |
(97 | ) | — | ||||||||
Charges for previously disclosed litigation matters | 17 | 14 | |||||||||
|
— | 1,084 | |||||||||
|
— | 34 | |||||||||
Gain on sale of |
— | (187 | ) | ||||||||
Operating profit, non-GAAP | $ | 3,985 | $ | 3,988 | — | % | |||||
|
|||||||||||
Operating Profit Margin | 2016 | 2015 | Change | ||||||||
Operating profit margin, GAAP | 25.3 | % | 17.4 | % | 790 | ||||||
2012 Restructuring Program | 1.5 | % | 1.6 | % | |||||||
Gain on sale of land in |
(0.7 | )% | — | % | |||||||
Charges for previously disclosed litigation matters | 0.1 | % | 0.1 | % | |||||||
|
— | % | 6.8 | % | |||||||
|
— | % | 0.2 | % | |||||||
Gain on sale of |
— | % | (1.2 | )% | |||||||
Operating profit margin, non-GAAP | 26.2 | % | 24.9 | % | 130 | ||||||
Table 9 | |||||||||||||||||||||||||||
Continued | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||||||||||||
For the Twelve Months Ended |
|||||||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||||||||||||
2016 | |||||||||||||||||||||||||||
Income |
Provision |
Net Income |
Less: |
Net Income |
Effective |
Diluted |
|||||||||||||||||||||
As Reported GAAP | $ | 3,738 | $ | 1,152 | $ | 2,586 | $ | 145 | $ | 2,441 | 30.8 | % | $ | 2.72 | |||||||||||||
2012 Restructuring Program | 228 | 59 | 169 | 1 | 168 | (0.3 | )% | 0.19 | |||||||||||||||||||
Gain on sale of land in |
(97 | ) | (34 | ) | (63 | ) | — | (63 | ) | (0.1 | )% | (0.07 | ) | ||||||||||||||
Benefits from previously disclosed tax |
— | 35 | (35 | ) | — | (35 | ) | 0.9 | % | (0.04 | ) | ||||||||||||||||
Charges for a previously disclosed |
17 | 6 | 11 | — | 11 | — | % | 0.01 | |||||||||||||||||||
Non-GAAP | $ | 3,886 | $ | 1,218 | $ | 2,668 | $ | 146 | $ | 2,522 | 31.3 | % | $ | 2.81 | |||||||||||||
2015 | |||||||||||||||||||||||||||
Income |
Provision |
Net Income |
Less: |
Net Income |
Effective |
Diluted |
|||||||||||||||||||||
As Reported GAAP | $ | 2,763 | $ | 1,215 | $ | 1,548 | $ | 164 | $ | 1,384 | 44.0 | % | $ | 1.52 | |||||||||||||
|
1,084 | 26 | 1,058 | — | 1,058 | (11.7 | )% | 1.16 | |||||||||||||||||||
2012 Restructuring Program | 254 | 69 | 185 | 2 | 183 | (0.3 | )% | 0.20 | |||||||||||||||||||
|
34 | 12 | 22 | — | 22 | — | % | 0.02 | |||||||||||||||||||
Gain on sale of |
(187 | ) | (67 | ) | (120 | ) | — | (120 | ) | (0.2 | )% | (0.13 | ) | ||||||||||||||
Charge for a previously disclosed |
14 | — | 14 | — | 14 | (0.1 | )% | 0.02 | |||||||||||||||||||
Charge for a previously disclosed tax |
— | (15 | ) | 15 | — | 15 | (0.4 | )% | 0.02 | ||||||||||||||||||
Non-GAAP | $ | 3,962 | $ | 1,240 | $ | 2,722 | $ | 166 | $ | 2,556 | 31.3 | % | $ | 2.81 |
Notes:
(1) The income tax effect on non-GAAP items is calculated
based upon the tax laws and statutory income tax rates applicable in the
tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.
(3) The impact of non-GAAP adjustments on Diluted earnings per share may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170127005097/en/
or
Source:
News Provided by Acquire Media